ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALCJ Crossject

2.31
0.00 (0.00%)
Last Updated: 02:01:47
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Crossject ALCJ Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 2.31 02:01:47
Open Price Low Price High Price Close Price Previous Close
2.35 2.31 2.35 2.31
more quote information »

Recent News

Date Time Source Heading
5/30/202403:30GLOBECrossject annonce la publication de données cliniques sur..
5/02/202410:30GLOBECrossject signe une extension géographique de l'accord de..
4/30/202412:05GLOBECrossject annonce le lancement d’une augmentation de capital
4/25/202400:32GLOBECrossject communique ses résultats financiers audités pour..
4/10/202409:30GLOBECrossject : Information relative au nombre total de droits..
4/02/202411:35GLOBELa cotation sur l’action de Crossject à Euronext reprendra..
4/02/202403:30GLOBECrossject poursuit sa stratégie de développement aux..
3/08/202400:30GLOBELe Score de l’index Egalité femmes-hommes chez Crossject..
2/27/202401:30GLOBECrossject obtient un financement jusqu’à 12 millions d’euros..
2/06/202410:30GLOBECrossject provides strategic update on priorities for 2024
2/01/202411:15GLOBECrossject organisera un webcast le 6 février à 17h30 pour..
1/16/202410:15GLOBECrossject : Information relative au nombre total de droits..
1/09/202409:21GLOBECrossject to present at Biotech Showcase on January 9 at..
1/04/202411:00GLOBECrossject engage Syneos Health pour le lancement commercial..
12/22/202300:30GLOBECrossject signe un accord de commercialisation pour..
12/20/202309:40GLOBECrossject : Information relative au nombre total de droits..
11/28/202300:30GLOBECrossject annonce l’initiation de la couverture de son titre..
11/14/202310:35GLOBECrossject : Information relative au nombre total de droits..
10/05/202301:45GLOBECrossject : Information relative au nombre total de droits..
9/26/202310:35GLOBECrossject reports financial results and business highlights..
9/11/202310:35GLOBECrossject : Information relative au nombre total de droits..
9/11/202300:30GLOBECrossject annonce une nouvelle nette amélioration de sa..
9/05/202306:00GLOBECrossject reports successful completion of European and U.S...
9/05/202300:30GLOBECrossject reports successful completion of European and U.S...
8/08/202310:49GLOBECrossject : Information relative au nombre total de droits..
7/24/202311:00GLOBECrossject : Information relative au nombre total de droits..
7/20/202309:55GLOBECrossject signs new licensing agreement on ZENEO® Midazolam..
7/20/202300:30GLOBECrossject signs new licensing agreement on ZENEO® Midazolam..
7/10/202311:00GLOBECROSSJECT - Information relative au nombre total de droits..
6/30/202301:30GLOBECrossject répond aux questions posées par les actionnaires..
6/12/202311:00GLOBECrossject à l'écoute de ses actionnaires individuels et des..
6/05/202311:00GLOBECROSSJECT - Information relative au nombre total de droits..

Your Recent History

Delayed Upgrade Clock